1. Home
  2. TSBX vs NAAS Comparison

TSBX vs NAAS Comparison

Compare TSBX & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • NAAS
  • Stock Information
  • Founded
  • TSBX 2015
  • NAAS 2019
  • Country
  • TSBX United States
  • NAAS China
  • Employees
  • TSBX N/A
  • NAAS N/A
  • Industry
  • TSBX
  • NAAS Other Specialty Stores
  • Sector
  • TSBX
  • NAAS Consumer Discretionary
  • Exchange
  • TSBX Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • TSBX 8.1M
  • NAAS 8.3M
  • IPO Year
  • TSBX 2023
  • NAAS 2017
  • Fundamental
  • Price
  • TSBX N/A
  • NAAS $2.70
  • Analyst Decision
  • TSBX Buy
  • NAAS
  • Analyst Count
  • TSBX 3
  • NAAS 0
  • Target Price
  • TSBX $4.75
  • NAAS N/A
  • AVG Volume (30 Days)
  • TSBX 149.2K
  • NAAS 227.0K
  • Earning Date
  • TSBX 08-18-2025
  • NAAS 08-19-2025
  • Dividend Yield
  • TSBX N/A
  • NAAS N/A
  • EPS Growth
  • TSBX N/A
  • NAAS N/A
  • EPS
  • TSBX N/A
  • NAAS N/A
  • Revenue
  • TSBX N/A
  • NAAS $27,534,354.00
  • Revenue This Year
  • TSBX N/A
  • NAAS $378.49
  • Revenue Next Year
  • TSBX N/A
  • NAAS N/A
  • P/E Ratio
  • TSBX N/A
  • NAAS N/A
  • Revenue Growth
  • TSBX N/A
  • NAAS N/A
  • 52 Week Low
  • TSBX $0.29
  • NAAS $1.96
  • 52 Week High
  • TSBX $2.45
  • NAAS $84.80
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 6.88
  • NAAS 47.40
  • Support Level
  • TSBX $0.35
  • NAAS $2.18
  • Resistance Level
  • TSBX $0.36
  • NAAS $2.70
  • Average True Range (ATR)
  • TSBX 0.01
  • NAAS 0.41
  • MACD
  • TSBX -0.02
  • NAAS 0.04
  • Stochastic Oscillator
  • TSBX 0.00
  • NAAS 51.97

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: